Literature DB >> 28982909

Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.

Satoru Motoyama1, Yusuke Sato2, Tomohiko Sasaki2, Akiyuki Wakita2, Yuta Kawakita2, Jiajia Liu2, Yushi Nagaki2, Hajime Saito2, Kazuhiro Imai2, Hayato Konno2, Kaori T Mizusawa2, Yoshihiro Minamiya2.   

Abstract

AIM: We investigated the safety of adding Japanese-style extended 3-field lymphadenectomy in patients treated with neoadjuvant chemoradiotherapy (NACRT) for thoracic esophageal squamous cell carcinoma (TESCC). Furthermore, the efficacy of NACRT, as shown by the pathological and metabolic responses were determined. PATIENTS AND METHODS: One hundred consecutive patients with cStage II-IV TESSC were enrolled. We analyzed the adverse events related to NACRT and surgical complications following surgery. Pathological responses to NACRT and the association between pCR and [18F]-fluorodeoxyglucose positron-emission tomography (FDG-PET) evaluation were investigated.
RESULTS: Adding Japanese-style extended 3-field lymph node dissection after NACRT did not increase serious surgical complications. Seventy-four percent of patients experienced grade 2-3 pathological response, with 25% achieving pCR. There was a significant relationship between the change from positive to negative findings on FDG-PET/CT and pCR.
CONCLUSION: Transthoracic esophagectomy with Japanese-style extended 3-field lymph node dissection after NACRT is a safe and powerful treatment. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  3-field lymphadenectomy; Neoadjuvant chemoradiotherapy; efficacy; esophageal cancer; esophagectomy; safety

Mesh:

Substances:

Year:  2017        PMID: 28982909     DOI: 10.21873/anticanres.12027

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Clinical significance and prognosis of supraclavicular lymph node metastasis in patients with thoracic esophageal cancer.

Authors:  Fudong Wang; Xiaosong Ge; Zhiqiang Wang; Yuan Weng; Rong Yin; Qingjun You
Journal:  Ann Transl Med       Date:  2020-02

2.  No Association Between MicroRNA-608 rs4919510 G>C Polymorphism and Digestive System Cancers Susceptibility: A Meta-Analysis Based on 10,836 Individuals.

Authors:  Xue-Feng Li; Ju-Kun Song; Jun-Wei Cai; Yu-Qin Zeng; Min Li; Jie Zhu; Yu-Ming Niu
Journal:  Front Physiol       Date:  2018-06-07       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.